SCHEDULE: Vanguard Discloses 6.97% Stake in Teladoc Health

Vanguard Portfolio Management has reported a beneficial ownership of 6.97% in Teladoc Health Inc. common stock as of March 31, 2026.

Summary

• Vanguard Portfolio Management, along with its affiliates Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC, now beneficially owns 12,451,266 shares of Teladoc Health Inc. common stock.
• This holding represents 6.97% of the total class of securities.
• The filing indicates that Vanguard Portfolio Management has sole dispositive power over these shares and sole voting power over 156,172 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of passive institutional ownership and does not provide new operational or financial information about Teladoc Health itself.

Positives

• Vanguard, a significant institutional investor, has disclosed a substantial ownership stake, which could be interpreted as a sign of confidence in Teladoc Health's long-term prospects by a major market participant.
• The filing confirms that Vanguard manages these shares in the ordinary course of business, suggesting a stable, long-term investment approach rather than a short-term activist play.

Negatives

• The filing is a Schedule 13G, which is an informational filing for passive investors, and does not provide any specific positive or negative operational or financial updates from Teladoc Health itself. The information is solely about Vanguard's holdings.

Risks

• While not explicitly stated as a risk in this filing, any significant change in Vanguard's holdings or investment strategy could impact Teladoc Health's stock price due to the size of their stake.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance from Teladoc Health.

Industry Context

StockSavvy.ai notes that the disclosure of a significant stake by a major asset manager like Vanguard in a company like Teladoc Health, operating in the competitive and evolving telehealth sector, often signals sustained institutional interest. Such filings can influence market perception and attract further investor attention to the company's strategic direction and performance.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by Vanguard may be viewed positively, potentially indicating institutional confidence and stability, which could influence share price.
• Management: The filing confirms Vanguard's passive investment approach, meaning they are not seeking to influence control, which provides clarity on the nature of this large shareholder.
• Creditors: A stable, large institutional investor can be seen as a positive indicator of the company's long-term viability.

Next Steps

• Vanguard will continue to hold the shares as per their investment strategy.
• Teladoc Health will continue its operations and report its financial results in subsequent filings.

Key Dates

Keywords

Teladoc Health, Vanguard, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Healthcare Technology, Telemedicine